Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited therapeutic options, and there is a huge unmet need for new therapies. A growing body of evidence suggests that the histone deacetylase (HDAC) family of transcriptional corepressors has emerged as crucial mediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Korfei, Martina, Mahavadi, Poornima, Guenther, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139813/
https://www.ncbi.nlm.nih.gov/pubmed/35626663
http://dx.doi.org/10.3390/cells11101626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139813/
https://www.ncbi.nlm.nih.gov/pubmed/35626663
http://dx.doi.org/10.3390/cells11101626

Ejemplares similares